{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:28:46Z","timestamp":1789140526858,"version":"build-2803163510"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jri.2024.104385","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:09:30Z","timestamp":1729141770000},"page":"104385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer"],"prefix":"10.1016","volume":"166","author":[{"given":"Julia","family":"Knabl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Desoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2024.104385_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103205","article-title":"Understanding HLA-G driven journey from HPV infection to cancer cervix: adding missing pieces to the jigsaw puzzle","volume":"142","author":"Aggarwal","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/657625","article-title":"Some basic aspects of HLA-G biology","volume":"2014","author":"Alegre","year":"2014","journal-title":"J. Immunol. Res"},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib3","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3892\/or.2020.7816","article-title":"Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state","volume":"44","author":"Alhammad","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jri.2024.104385_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.meegid.2015.06.027","article-title":"The effect of human leukocyte antigen G alleles on human papillomavirus infection and persistence in a cohort of HIV-positive pregnant women from Brazil","volume":"34","author":"Alves","year":"2015","journal-title":"Infect. Genet Evol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.humimm.2018.02.012","article-title":"Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma","volume":"79","author":"Babay","year":"2018","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib6","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4049\/jimmunol.163.4.2023","article-title":"Little evidence of HLA-G mRNA polymorphism in Caucasian or Afro-Caribbean populations","volume":"163","author":"Bainbridge","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0378(00)00056-5","article-title":"The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface","volume":"47","author":"Bainbridge","year":"2000","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2006.01.045","article-title":"Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma","volume":"103","author":"Barrier","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jri.2024.104385_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2018.04.007","article-title":"Increased plasmatic soluble HLA-G levels in endometrial cancer","volume":"99","author":"Ben Yahia","year":"2018","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.humimm.2020.03.008","article-title":"Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer","volume":"81","author":"Ben Yahia","year":"2020","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.24852","article-title":"The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer","volume":"126","author":"Bijen","year":"2010","journal-title":"Int J. Cancer"},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/tan.12281","article-title":"Implication of HLA-G 3\u2032 untranslated region polymorphisms in human papillomavirus infection","volume":"83","author":"Bortolotti","year":"2014","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib13","first-page":"82","article-title":"The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases","volume":"52","author":"Brenol","year":"2012","journal-title":"Rev. Bras. Reum."},{"key":"10.1016\/j.jri.2024.104385_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.placenta.2017.01.130","article-title":"Oxygen and placental development; parallels and differences with tumour biology","volume":"56","author":"Burton","year":"2017","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1471-4906(01)02007-5","article-title":"HLA-G: a shield against inflammatory aggression","volume":"22","author":"Carosella","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.jri.2024.104385_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2014.00476","article-title":"Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity","volume":"5","author":"Castelli","year":"2014","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.jri.2024.104385_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.humimm.2010.06.009","article-title":"Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer","volume":"71","author":"Chen","year":"2010","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2004.09.049","article-title":"HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma","volume":"96","author":"Davidson","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib20","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41598-018-24009-7","article-title":"The genetic diversity within the 1.4 kb HLA-G 5\u2032 upstream regulatory region moderately impacts on cellular microenvironment responses","volume":"8","author":"Dias","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1933719110369183","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16\/18 infection, and host immune response","volume":"17","author":"Dong","year":"2010","journal-title":"Reprod. Sci."},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib22","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.humimm.2012.07.321","article-title":"Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer","volume":"73","author":"Dong","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib24","first-page":"153","article-title":"Human leukocyte antigen G expression in breast cancer: role in immunosuppression","volume":"26","author":"Elliott","year":"2011","journal-title":"Cancer Biother Radio."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.1990.tb00677.x","article-title":"HLA G: at the interface","volume":"23","author":"Ellis","year":"1990","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/CBM-130364","article-title":"Association between HLA-G 3\u2032UTR 14-bp ins\/del polymorphism and susceptibility to breast cancer","volume":"13","author":"Eskandari-Nasab","year":"2013","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib27","first-page":"125","article-title":"Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response","volume":"25","author":"Fahim","year":"2018","journal-title":"Egypt J. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00018-010-0584-3","article-title":"Emerging topics and new perspectives on HLA-G","volume":"68","author":"Fainardi","year":"2011","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1096\/fj.09-135194","article-title":"ILT2\/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse","volume":"24","author":"Favier","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jri.2024.104385_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40425-016-0184-3","article-title":"Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases","volume":"4","author":"Ferns","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"19","key":"10.1016\/j.jri.2024.104385_bib31","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1073\/pnas.1602886113","article-title":"A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface","volume":"113","author":"Ferreira","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib32","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood-2005-12-019919","article-title":"Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells","volume":"108","author":"Fons","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jri.2024.104385_bib33","doi-asserted-by":"crossref","first-page":"1076040","DOI":"10.3389\/fimmu.2022.1076040","article-title":"HLA-G 3\u2032UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis","volume":"13","author":"Gan","year":"2022","journal-title":"Front Immunol."},{"issue":"20","key":"10.1016\/j.jri.2024.104385_bib34","doi-asserted-by":"crossref","first-page":"15232","DOI":"10.1074\/jbc.275.20.15232","article-title":"Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha","volume":"275","author":"Gao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2024.104385_bib35","first-page":"618","article-title":"Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis","volume":"12","author":"Gillio-Tos","year":"2012"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/molehr\/6.1.88","article-title":"Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia","volume":"6","author":"Goldman-Wohl","year":"2000","journal-title":"Mol. Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonzalez","year":"2012","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1369\/jhc.2009.954131","article-title":"Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV)","volume":"58","author":"Guimaraes","year":"2010","journal-title":"J. Histochem Cytochem"},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12643","article-title":"Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition","volume":"77","author":"Hackmon","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/aid.2010.0165","article-title":"HLA-G 14-bp insertion\/deletion polymorphism is a risk factor for HTLV-1 infection","volume":"27","author":"Haddad","year":"2011","journal-title":"AIDS Res Hum. Retrovir."},{"issue":"14","key":"10.1016\/j.jri.2024.104385_bib41","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.7314\/APJCP.2015.16.14.6155","article-title":"14-bp Insertion\/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran","volume":"16","author":"Haghi","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09674845.2020.1856495","article-title":"Certain haplotypes of the 3\u2032-UTR region of the HLA-G gene are linked to breast cancer","volume":"78","author":"Haghi","year":"2021","journal-title":"Br. J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib43","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1245\/s10434-009-0891-9","article-title":"HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro","volume":"17","author":"He","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1096\/fj.04-2078rev","article-title":"HLA-G and immune tolerance in pregnancy","volume":"19","author":"Hunt","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1169356","article-title":"Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy","volume":"5","author":"Ishibashi","year":"2016","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003050","article-title":"Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors","volume":"9","author":"Jan","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098284","article-title":"Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients","volume":"9","author":"Jeong","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib48","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181991","article-title":"Genetic variation in the HLA-G 3\u2032UTR 14-bp insertion\/deletion and the associated cancer risk: evidence from 25 case-control studies","volume":"39","author":"Jiang","year":"2019","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124307","article-title":"Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-gamma Stimulation and Inhibition of DNA Methylation","volume":"21","author":"Jorgensen","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jri.2024.104385_bib50","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1933719109342131","article-title":"Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer","volume":"16","author":"Jung","year":"2009","journal-title":"Reprod. Sci."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jclinpath-2019-205772","article-title":"Association of HLA-G 3\u2032UTR 14-bp Ins\/Del polymorphism with breast cancer among South Indian women","volume":"73","author":"Kadiam","year":"2020","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molehr\/7.2.195","article-title":"Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture","volume":"7","author":"Kanai","year":"2001","journal-title":"Mol. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2567.2000.00109.x","article-title":"HLA-G has a concentration-dependent effect on the generation of an allo-CTL response","volume":"101","author":"Kapasi","year":"2000","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00428-005-0144-7","article-title":"Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma","volume":"449","author":"Kleinberg","year":"2006","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00418-022-02163-4","article-title":"Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controls","volume":"159","author":"Knabl","year":"2023","journal-title":"Histochem Cell Biol."},{"issue":"9","key":"10.1016\/j.jri.2024.104385_bib57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients","volume":"77","author":"Konig","year":"2016","journal-title":"Hum. Immunol."},{"issue":"21","key":"10.1016\/j.jri.2024.104385_bib58","first-page":"7167","article-title":"Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis","volume":"63","author":"Korkola","year":"2003","journal-title":"Cancer Res"},{"issue":"4952","key":"10.1016\/j.jri.2024.104385_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib60","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0897.1996.tb00034.x","article-title":"Placental expression of HLA class I genes","volume":"35","author":"Le Bouteiller","year":"1996","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1 Pt 2","key":"10.1016\/j.jri.2024.104385_bib62","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0368-2315(04)96396-X","article-title":"[The role of HLA-G expression in the embryo during implantation]","volume":"33","author":"Le Bouteiller","year":"2004","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"issue":"1-2","key":"10.1016\/j.jri.2024.104385_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jri.2007.03.007","article-title":"Soluble HLA-G and control of angiogenesis","volume":"76","author":"Le Bouteiller","year":"2007","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0923-2494(96)89643-X","article-title":"Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story","volume":"147","author":"Le Bouteiller","year":"1996","journal-title":"Res Immunol."},{"issue":"11","key":"10.1016\/j.jri.2024.104385_bib65","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib66","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/11.8.1351","article-title":"HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes","volume":"11","author":"Le Gal","year":"1999","journal-title":"Int Immunol."},{"issue":"11","key":"10.1016\/j.jri.2024.104385_bib67","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0198-8859(00)00192-0","article-title":"Modulation of HLA-G expression in human thymic and amniotic epithelial cells","volume":"61","author":"Lefebvre","year":"2000","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/path.1039","article-title":"Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer","volume":"196","author":"Lefebvre","year":"2002","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib69","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1096\/fj.04-1617fje","article-title":"HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells","volume":"19","author":"LeMaoult","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jri.2024.104385_bib70","article-title":"HLA-G\/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib71","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00438-014-0985-3","article-title":"Genetic polymorphism in HLA-G 3\u2032UTR 14-bp ins\/del and risk of cancer: a meta-analysis of case-control study","volume":"290","author":"Li","year":"2015","journal-title":"Mol. Genet Genom."},{"issue":"9","key":"10.1016\/j.jri.2024.104385_bib72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.humimm.2012.07.041","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression","volume":"73","author":"Li","year":"2012","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ijc.26375","article-title":"HLA-G expression is associated with metastasis and poor survival in the Balb\/c nu\/nu murine tumor model with ovarian cancer","volume":"131","author":"Lin","year":"2012","journal-title":"Int J. Cancer"},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.humimm.2012.11.021","article-title":"Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression","volume":"74","author":"Lin","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib75","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3389\/fimmu.2018.02164","article-title":"Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0952-7915(99)80048-X","article-title":"Natural killer cell activation and inhibition by receptors for MHC class I","volume":"11","author":"L\u00f3pez-Botet","year":"1999","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.jri.2024.104385_bib77","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/ijc.28845","article-title":"In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance","volume":"135","author":"Loumagne","year":"2014","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.jri.2024.104385_bib78","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3389\/fimmu.2020.01685","article-title":"HLA-G Neo-Expression on Tumors","volume":"11","author":"Loustau","year":"2020","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41371-018-0062-1","article-title":"Decreased expression of JHDMID in placenta is associated with preeclampsia through HLA-G","volume":"32","author":"Luo","year":"2018","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0897.1997.tb00279.x","article-title":"Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines","volume":"38","author":"Maejima","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033395","article-title":"MiRNA-mediated control of HLA-G expression and function","volume":"7","author":"Manaster","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08830185.2020.1869732","article-title":"HLA-G expression in melanomas","volume":"40","author":"Marletta","year":"2021","journal-title":"Int Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204679","article-title":"Variation sites at the HLA-G 3\u2032 untranslated region confer differential susceptibility to HIV\/HPV co-infection and aneuploidy in cervical cell","volume":"13","author":"Medeiros","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jri.2024.104385_bib84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clim.2017.09.004","article-title":"HLA class Ia and Ib molecules and FOXP3+ TILs in relation to the prognosis of malignant melanoma patients","volume":"183","author":"Melsted","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-7-43","article-title":"Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors","volume":"7","author":"Menendez","year":"2008","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.10460","article-title":"MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal","volume":"100","author":"Menier","year":"2002","journal-title":"Int J. Cancer"},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib87","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","article-title":"Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis","volume":"104","author":"Menier","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib88","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.humimm.2009.07.021","article-title":"Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology","volume":"70","author":"Menier","year":"2009","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib89","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.humimm.2013.08.279","article-title":"The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec","volume":"74","author":"Metcalfe","year":"2013","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib90","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/1516-3180.2013.7170009","article-title":"Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study","volume":"133","author":"Miranda","year":"2015","journal-title":"Sao Paulo Med J."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib91","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.humimm.2012.12.014","article-title":"Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?","volume":"74","author":"Mociornita","year":"2013","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011763","article-title":"A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis","volume":"5","author":"Morandi","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","article-title":"IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes","volume":"11","author":"Moreau","year":"1999","journal-title":"Int Immunol."},{"issue":"9b","key":"10.1016\/j.jri.2024.104385_bib94","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1111\/j.1582-4934.2009.00800.x","article-title":"Non-classical transcriptional regulation of HLA-G: an update","volume":"13","author":"Moreau","year":"2009","journal-title":"J. Cell Mol. Med"},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.humimm.2006.10.016","article-title":"Hypoxia modulates HLA-G gene expression in tumor cells","volume":"68","author":"Mouillot","year":"2007","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1541-7786.MCR-14-0150","article-title":"Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenstr\u00f6m Macroglobulinemia","volume":"13","author":"Muz","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib97","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.humimm.2006.10.017","article-title":"Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2\/ILT-4\/FasL-mediated pathways","volume":"68","author":"Naji","year":"2007","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib98","first-page":"178","article-title":"Natural Killer Cell Cytotoxicity Against SKOV3 after HLA-G Downregulation by shRNA","volume":"13","author":"Nazari","year":"2016","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.jri.2024.104385_bib99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01192.x","article-title":"Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G","volume":"163","author":"O'Callaghan","year":"1998","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10517-015-3038-y","article-title":"Content of HLA-G(+) T Cells in the peripheral blood from healthy women and breast cancer patients.","volume":"159","author":"Ostapchuk","year":"2015","journal-title":"Bull. Exp. Biol. Med"},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib101","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10517-016-3224-6","article-title":"Erratum to: Content of HLA-G(+) T Cells in the Peripheral Blood from Healthy Women and Breast Cancer Patients","volume":"160","author":"Ostapchuk","year":"2016","journal-title":"Bull. Exp. Biol. Med"},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib102","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08820139.2019.1569043","article-title":"The Impact of HLA-G 3\u2032UTR Polymorphisms in Breast Cancer in a Tunisian Population","volume":"48","author":"Ouni","year":"2019","journal-title":"Immunol. Invest"},{"issue":"4 Pt 1","key":"10.1016\/j.jri.2024.104385_bib103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1399-0039.1999.530403.x","article-title":"HLA-G protein expression is not induced during malignant transformation","volume":"53","author":"Pangault","year":"1999","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib104","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","article-title":"HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance","volume":"95","author":"Paul","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib105","first-page":"1954","article-title":"Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies","volume":"59","author":"Paul","year":"1999","journal-title":"Cancer Res"},{"issue":"8-9","key":"10.1016\/j.jri.2024.104385_bib106","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00251-017-0988-4","article-title":"HLA class Ib in pregnancy and pregnancy-related disorders","volume":"69","author":"Persson","year":"2017","journal-title":"Immunogenetics"},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib107","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1073\/pnas.96.10.5674","article-title":"Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94\/NKG2A and acquire p49, an HLA-G1-specific receptor","volume":"96","author":"Ponte","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib108","first-page":"1021","article-title":"Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy","volume":"32","author":"Provatopoulou","year":"2012","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib109","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humimm.2014.10.009","article-title":"A combination of single nucleotide polymorphisms in the 3\u2032untranslated region of HLA-G is associated with preeclampsia","volume":"75","author":"Quach","year":"2014","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib111","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.humimm.2014.04.005","article-title":"Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma","volume":"75","author":"Ramos","year":"2014","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib112","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1044-579X(03)00028-2","article-title":"Secretion of sHLA-G molecules in malignancies","volume":"13","author":"Rebmann","year":"2003","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.jri.2024.104385_bib113","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297073","article-title":"HLA-G as a tolerogenic molecule in transplantation and pregnancy","volume":"2014","author":"Rebmann","year":"2014","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.jri.2024.104385_bib114","article-title":"Systematic Evaluation of HLA-G 3\u2032Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome","volume":"12","author":"Rebmann","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib115","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.200425741","article-title":"Tolerization of dendritic cells by HLA-G","volume":"35","author":"Ristich","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/iji.12092","article-title":"HLA-G polymorphism and breast cancer","volume":"41","author":"Rolfsen","year":"2014","journal-title":"Int J. Immunogenet."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/scbi.1998.0103","article-title":"The immunotolerance role of HLA-G","volume":"9","author":"Rouas-Freiss","year":"1999","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ijc.21151","article-title":"Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis","volume":"117","author":"Rouas-Freiss","year":"2005","journal-title":"Int J. Cancer"},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib119","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10815-007-9148-3","article-title":"HLA-G and its role in implantation (review)","volume":"24","author":"Roussev","year":"2007","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.jri.2024.104385_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/274584","article-title":"HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas","volume":"2014","author":"Rutten","year":"2014","journal-title":"J. Immunol. Res"},{"issue":"25","key":"10.1016\/j.jri.2024.104385_bib121","doi-asserted-by":"crossref","first-page":"40935","DOI":"10.18632\/oncotarget.16783","article-title":"Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment","volume":"8","author":"Sato","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib122","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1399-0039.2009.01393.x","article-title":"HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients","volume":"75","author":"Sayed","year":"2010","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib123","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1038\/s41598-019-41900-z","article-title":"HLA-G 3\u2032 untranslated region variants +3187G\/G, +3196G\/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer","volume":"9","author":"Schwich","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jri.2024.104385_bib124","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2020.02046","article-title":"Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary","volume":"11","author":"Schwich","year":"2020","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2007.06.012","article-title":"Ie, Clinical and biological significance of HLA-G expression in ovarian cancer.","volume":"17","author":"Sheu","year":"2007","journal-title":"Semin Cancer Biol."},{"issue":"15","key":"10.1016\/j.jri.2024.104385_bib126","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jri.2024.104385_bib127","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/250435","article-title":"Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer","volume":"2013","author":"da Silva","year":"2013","journal-title":"Int J. Breast Cancer"},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.humimm.2012.11.025","article-title":"HLA-G 3\u2032UTR polymorphisms in high grade and invasive cervico-vaginal cancer","volume":"74","author":"Silva","year":"2013","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.humimm.2023.04.007","article-title":"Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection","volume":"84","author":"da Silva","year":"2023","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/modpathol.2009.67","article-title":"HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus","volume":"22","author":"Sim\u00f5es","year":"2009","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.jri.2024.104385_bib131","first-page":"4460","article-title":"HLA-G is a potential tumor marker in malignant ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib132","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00251-001-0373-0","article-title":"HLA-G unique promoter region: functional implications","volume":"53","author":"Solier","year":"2001","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib133","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/ijo.2016.3589","article-title":"Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer","volume":"49","author":"Sun","year":"2016","journal-title":"Int J. Oncol."},{"issue":"7","key":"10.1016\/j.jri.2024.104385_bib134","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.humimm.2013.03.003","article-title":"The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3\u2032-untranslated region","volume":"74","author":"Svendsen","year":"2013","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2014.07.073","article-title":"GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer","volume":"451","author":"Tao","year":"2014","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.jri.2024.104385_bib136","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2022.06.010","article-title":"3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis","volume":"248","author":"Tizaoui","year":"2022","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.jri.2024.104385_bib137","first-page":"385","article-title":"Immunopathogenesis of ovarian cancer","volume":"100","author":"Torres","year":"2009","journal-title":"Minerva Med"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5507\/bp.2005.006","article-title":"Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas","volume":"149","author":"Turashvili","year":"2005","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib139","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/2326-6066.CIR-14-0199","article-title":"The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion","volume":"3","author":"Ueshima","year":"2015","journal-title":"Cancer Immunol. Res"},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neo.2019.01.001","article-title":"High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1beta","volume":"21","author":"Ullah","year":"2019","journal-title":"Neoplasia"},{"issue":"4-5","key":"10.1016\/j.jri.2024.104385_bib141","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0171-2985(11)80222-6","article-title":"Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions","volume":"188","author":"Viac","year":"1993","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13070","article-title":"The analysis of human leukocyte antigen-G level in patients with endometrial cancer by Western blot technique","volume":"81","author":"Walentowicz-Sadlecka","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib143","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1038\/s41598-020-72837-3","article-title":"HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment","volume":"10","author":"Wuerfel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jri.2024.104385_bib144","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13027-018-0217-2","article-title":"Association of HLA-G 3\u2032 UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections","volume":"13","author":"Xu","year":"2018","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.jri.2024.104385_bib145","article-title":"A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib146","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1007\/s00432-022-04331-4","article-title":"Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy","volume":"149","author":"Xu","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib147","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.cr.7290283","article-title":"Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition","volume":"15","author":"Yan","year":"2005","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib148","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejca.2013.10.018","article-title":"Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women","volume":"50","author":"Yang","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib149","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2004.01.033","article-title":"HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia","volume":"191","author":"Yie","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.jri.2024.104385_bib150","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/humrep\/del126","article-title":"Progesterone regulates HLA-G gene expression through a novel progesterone response element","volume":"21","author":"Yie","year":"2006","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.jri.2024.104385_bib151","first-page":"4709","article-title":"Role of gene promoter methylation regulated by TETs and DNMTs in the overexpression of HLA-G in MCF-7 cells","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med"},{"issue":"8","key":"10.1016\/j.jri.2024.104385_bib152","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0b013e318186fccd","article-title":"Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts","volume":"86","author":"Zhang","year":"2008","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jri.2024.104385_bib153","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.humimm.2015.12.003","article-title":"Lesion HLA-G5\/-G6 isoforms expression in patients with ovarian cancer","volume":"77","author":"Zhang","year":"2016","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2024.104385_bib154","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-021-00629-w","article-title":"Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab","volume":"6","author":"Zheng","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.jri.2024.104385_bib155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1399-0039.2010.01607.x","article-title":"Up-regulation of HLA-G expression in cervical premalignant and malignant lesions","volume":"77","author":"Zheng","year":"2011","journal-title":"Tissue Antigens"},{"issue":"22","key":"10.1016\/j.jri.2024.104385_bib156","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2005.10.039","article-title":"Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma","volume":"78","author":"Zhou","year":"2006","journal-title":"Life Sci."},{"issue":"22","key":"10.1016\/j.jri.2024.104385_bib157","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00018-006-6341-y","article-title":"Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers","volume":"63","author":"Zidi","year":"2006","journal-title":"Cell Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.jri.2024.104385_bib158","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12026-015-8782-6","article-title":"Association of HLA-G +3142C>G polymorphism and breast cancer in Tunisian population","volume":"64","author":"Zidi","year":"2016","journal-title":"Immunol. Res"},{"issue":"2","key":"10.1016\/j.jri.2024.104385_bib159","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12026-015-8764-8","article-title":"Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?","volume":"64","author":"Zidi","year":"2016","journal-title":"Immunol. Res"}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037824001943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037824001943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T21:39:22Z","timestamp":1733434762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037824001943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":159,"alternative-id":["S0165037824001943"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2024.104385","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2024.104385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104385"}}